InicioCarterasWatchlistComunidadDescubreScreener
NOT FOR DISTRIBUTION

Dolby Laboratories, Inc.

Informe acción NYSE:DLB

Capitalización de mercado: US$5.8b

  • Resumen empresa
  • Valoración
  • Crecimiento Futuro
  • Rendimiento pasado
  • Salud Financiera
  • Dividendos
  • Dirección
  • Propiedad
  • Información adicional
  • Comunidad de acciones

Dolby Laboratories Crecimiento futuro

Future controles de criterios 1/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Dolby Laboratories de 17.1% y 5.4% respectivamente, mientras que el BPA crecerá en un 19% al año.

Información clave

17.1%

Tasa de crecimiento de los beneficios

19.04%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Software20.5%
Tasa de crecimiento de los ingresos5.4%
Rentabilidad financiera futuran/a
Cobertura de analistas

Low

Última actualización27 Aug 2026

Actualizaciones recientes sobre el crecimiento futuro

Artículo de análisis • Feb 02

Dolby Laboratories, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Investors in Dolby Laboratories, Inc. ( NYSE:DLB ) had a good week, as its shares rose 3.3% to close at US$64.19...

Recent updates

User avatar
Actualización de narrativa • Aug 04

DLB: Streaming Partnerships And Buybacks Will Support Measured Future Return Potential

Analysts have nudged their fair value estimate for Dolby Laboratories higher from $60.00 to $62.00, citing updated assumptions that include a revised discount rate, revenue growth outlook, profit margin profile, and future P/E expectation. What’s in the News for Dolby Laboratories Dolby Laboratories reported Q3 fiscal 2026 revenue of US$305 million and GAAP net income of US$29 million, with growth cited in its Video Distribution Program and Dolby OptiView technology.
Seeking Alpha • Jul 20

Dolby Laboratories Valuation Is Compelling Ahead Of Earnings

Summary Dolby Laboratories is now undervalued after a 50%+ decline from its all-time high, trading at 18.7x FCF and 19.7x earnings. DLB's revenue growth remains choppy, but licensing—especially in Broadcast and Mobile—drives solid results and offers mid-single-digit growth potential. Expansion into automotive and increased adoption of Dolby Atmos/Vision by major platforms and automakers support future growth, with modest price increases feasible. I expect DLB to deliver a steady, 'boring' 10% annual return, making it a solid long-term investment at current valuations. Read the full article on Seeking Alpha
User avatar
Actualización de narrativa • Jul 03

DLB: Streaming Partnerships And Buybacks Will Support Future Upside Potential

Analysts have reduced their fair value estimate for Dolby Laboratories from $68.00 to $60.00. They cite more conservative revenue growth assumptions and a lower future P/E multiple, partly offset by slightly stronger projected profit margins and a modestly higher discount rate.
Artículo de análisis • Jun 20

Dolby Laboratories (DLB) Stock Could Be 33.2% Undervalued After Hitting A One Year Low

Dolby Laboratories (DLB) has slipped to a one year low as technical signals turned negative and selling pressure picked up, even though reported earnings and institutional ownership data continue to point to steady underlying operations. See our latest analysis for Dolby Laboratories. Over the past year, Dolby Laboratories' share price return has steadily weakened, with the stock down 17.63% year to date and the 1 year total shareholder return declining 26.01%. The 5 year total shareholder...
User avatar
Actualización de narrativa • Jun 18

DLB: World Cup Streaming Deal Will Support Future Share Price Recovery

Analysts have maintained their fair value estimate for Dolby Laboratories at $78.33 per share. Only minor model adjustments to the discount rate, revenue growth, profit margin, and future P/E assumptions were made, resulting in an unchanged price target.
User avatar
Actualización de narrativa • Jun 04

DLB: Immersive Content Partnerships Will Support Future Share Price Recovery

Analysts have kept their fair value estimate for Dolby Laboratories steady at $78.33, with only very small tweaks to inputs such as the discount rate, long term revenue growth, profit margin and future P/E assumptions guiding the updated price target narrative. What's in the News Dolby reported Q1 revenue growth of 7.1% year over year, topping analyst expectations by 2.8%, while issuing revenue and EPS guidance for the next quarter that came in below market forecasts, contributing to an 11% share price decline after the release.
User avatar
Actualización de narrativa • May 17

DLB: Expanding Premium Audio Partnerships Will Support Future Share Gains

Analysts have nudged their price target for Dolby Laboratories down from about $81 to roughly $78, reflecting updated assumptions that combine slightly adjusted revenue growth and discount rate inputs with a different outlook on profit margins and future P/E levels. What's in the News Dolby repurchased 1,010,900 shares between December 27, 2025 and March 27, 2026 for US$65 million, bringing total buybacks under its November 3, 2009 authorization to 54,327,604 shares (52.77%) for US$3,159.61 million (company buyback filing).
User avatar
Actualización de narrativa • May 01

DLB: Expanding Premium Audio Partnerships Will Support Future Share Gains

Analysts have adjusted their price target for Dolby Laboratories from $90.50 to $81.00, reflecting updated assumptions around the discount rate, revenue growth, profit margins, and future P/E expectations. What's in the News Dolby Atmos is being introduced in the new BMW 7 Series through BMW's Bowers & Wilkins Diamond Surround Sound System, which includes up to 36 speakers and 1,965 watts and is aimed at creating a three-dimensional in-car listening experience (Key Developments).
User avatar
Actualización de narrativa • Apr 17

DLB: Expanding Premium Cinema Footprint And Ongoing Buybacks Will Support Upside

Analysts are keeping their price target for Dolby Laboratories steady at $90.00. They point to only minor adjustments in the discount rate, revenue growth assumptions and profit margin outlook, along with a slightly lower future P/E multiple in their refreshed models.
User avatar
Actualización de narrativa • Apr 03

DLB: Future Streaming Expansion And Ongoing Buybacks Will Support Upside Outlook

Analysts have maintained their $90.00 price target for Dolby Laboratories, reflecting updated assumptions that include a slightly lower discount rate, modestly higher revenue growth and profit margin, and a slightly reduced future P/E multiple. What's in the News From September 27, 2025 to December 26, 2025, Dolby repurchased 1,044,838 shares for US$70 million, representing 1.09% of shares, completing a total of 53,316,704 shares repurchased for US$3,094.61 million under the buyback announced on November 3, 2009 (company filing).
User avatar
Actualización de narrativa • Mar 19

DLB: Future Streaming Technology Adoption Will Support A More Optimistic Outlook

Analysts have revised their price target for Dolby Laboratories from $114.00 to $90.00. They cite updated assumptions around revenue growth, profit margins, and a lower future P/E multiple as key drivers of the change.
User avatar
Actualización de narrativa • Mar 05

DLB: Media Partnerships And Buybacks Will Support Measured Future Returns

Analysts are keeping their price target for Dolby Laboratories steady at $68.00. This points to largely unchanged expectations around fair value, discount rate, revenue growth, profit margin and future P/E assumptions.
User avatar
Actualización de narrativa • Feb 19

DLB: Broad Media Partnerships And Buybacks Will Support Steady Returns

Analysts maintained their Dolby Laboratories fair value estimate at $68.00, with only minor adjustments to assumptions around discount rate, revenue growth, profit margin, and future P/E informing the updated price target rationale. What's in the News Dolby updated earnings guidance for the second quarter of fiscal 2026, with total revenue estimated at US$375 million to US$405 million and GAAP diluted EPS expected at US$0.94 to US$1.09.
User avatar
Actualización de narrativa • Feb 04

DLB: Ongoing Technology Adoption Will Support Returns Despite Choppy Macro Conditions

Analysts have trimmed their price targets on Dolby Laboratories to a range of about $85 to $95. This reflects a more cautious stance on the stock while still pointing to solid recent results and ongoing technology adoption, even as the macro backdrop pressures some revenue streams.
Artículo de análisis • Feb 02

Dolby Laboratories, Inc. Beat Analyst Estimates: See What The Consensus Is Forecasting For This Year

Investors in Dolby Laboratories, Inc. ( NYSE:DLB ) had a good week, as its shares rose 3.3% to close at US$64.19...
User avatar
Actualización de narrativa • Jan 21

DLB: Technology Adoption And Solid Execution Will Support Future Share Gains

Narrative Update on Dolby Laboratories The analyst price target for Dolby Laboratories has shifted down to a range of about $85 to $95 per share. Analysts point to a solid fiscal Q4, guidance in line with expectations, and continued technology adoption despite macro headwinds as key reasons for the updated view.
User avatar
Actualización de narrativa • Jan 06

DLB: Steady Outlook Will Balance Macro Pressures And Expanding Technology Adoption

Analysts have trimmed their price targets for Dolby Laboratories, with recent moves from $100 to $95 and from $95 to $85, as they weigh steady guidance and progress in technology adoption against ongoing macro headwinds affecting foundational revenues. Analyst Commentary Recent research updates show that bearish analysts are trimming their expectations for Dolby Laboratories even as they acknowledge stable guidance and a solid fiscal fourth quarter.
Artículo de análisis • Jan 05

Is There An Opportunity With Dolby Laboratories, Inc.'s (NYSE:DLB) 42% Undervaluation?

Key Insights The projected fair value for Dolby Laboratories is US$109 based on 2 Stage Free Cash Flow to Equity...
User avatar
Actualización de narrativa • Dec 21

DLB: Cautious Outlook Will Weigh On Shares Despite Expanding Technology Adoption

Analysts have trimmed their fair value estimate for Dolby Laboratories from $74.00 to $68.00, citing slightly higher discount-rate assumptions despite improving revenue growth and profit margin expectations. They continue to support maintaining a constructive long term outlook.
User avatar
Actualización de narrativa • Dec 07

DLB: Durable Business Model Will Support Future Gains Despite Macro Headwinds

Analysts have trimmed their price targets for Dolby Laboratories by roughly 10 dollars to reflect ongoing macro headwinds to foundational revenues. At the same time, they highlight solid quarterly execution and continued adoption of the company’s technologies as support for maintaining positive ratings.
User avatar
Actualización de narrativa • Nov 23

DLB: Durable Business Model Will Support Long-Term Stability Amid Macroeconomic Headwinds

Analysts have reduced their fair value price target for Dolby Laboratories from $95.75 to $90.50, citing continued macroeconomic headwinds but also recognizing progress in revenue growth and profitability. Analyst Commentary Recent Street research highlights a mix of optimism about Dolby Laboratories' underlying business strengths and caution regarding ongoing macroeconomic challenges.
Artículo de análisis • Nov 11

The Returns At Dolby Laboratories (NYSE:DLB) Aren't Growing

If you're not sure where to start when looking for the next multi-bagger, there are a few key trends you should keep an...
Artículo de análisis • Sep 27

Investor Optimism Abounds Dolby Laboratories, Inc. (NYSE:DLB) But Growth Is Lacking

When close to half the companies in the United States have price-to-earnings ratios (or "P/E's") below 19x, you may...
User avatar
Actualización de narrativa • Sep 06

Expanding Auto And Device Ecosystems Will Define Immersive Entertainment

Despite Dolby Laboratories' durable business model, growing licensing revenues, and long-term growth potential from strategic partnerships, analysts have trimmed the price target from $103.00 to $95.75 due to uninspiring device markets, macroeconomic uncertainty, and a lack of near-term catalysts. Analyst Commentary Growing licensing revenues and increased adoption across key markets support positive sentiment.

Previsiones de crecimiento de beneficios e ingresos

NYSE:DLB - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
FechaIngresosBeneficiosFlujo de caja libreFlujo de caja operativoNúm. de analistas medio
9/30/20281,5353495395672
9/30/20271,4672924935214
9/30/20261,4202564144494
6/26/20261,354226361438N/A
3/27/20261,365244265338N/A
12/26/20251,339241386420N/A
9/26/20251,349255430472N/A
6/27/20251,347264438466N/A
3/28/20251,320257390419N/A
12/27/20241,315263395426N/A
9/27/20241,274262297327N/A
6/28/20241,259212265296N/A
3/29/20241,269190365396N/A
12/29/20231,280188290319N/A
9/29/20231,300201337367N/A
6/30/20231,287219301333N/A
3/31/20231,279242348385N/A
12/30/20221,237183303343N/A
9/30/20221,254184259319N/A
7/1/20221,261201316377N/A
4/1/20221,258216314377N/A
12/31/20211,243255332397N/A
9/24/20211,281310393448N/A
6/25/20211,267293398451N/A
3/26/20211,228306359413N/A
12/25/20201,260318334395N/A
9/25/20201,162231275344N/A
6/26/20201,189248287362N/A
3/27/20201,245221N/A319N/A
12/27/20191,231206N/A302N/A
9/27/20191,242255N/A328N/A
6/28/20191,183238N/A309N/A
3/29/20191,096201N/A360N/A
12/28/20181,057193N/A392N/A
9/28/20181,05542N/A352N/A
6/29/20181,05637N/A321N/A
3/30/20181,147110N/A317N/A
12/29/20171,11595N/A324N/A
9/29/20171,080206N/A378N/A
6/30/20171,072204N/A370N/A
3/31/20171,044192N/A359N/A
12/30/20161,051208N/A360N/A
9/30/20161,026186N/A360N/A
7/1/20161,025208N/A367N/A
4/1/2016980180N/A288N/A
1/1/2016977171N/A373N/A
9/25/2015971181N/A309N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (17.1% al año) de DLB es superior a la tasa de ahorro (3.7%).

Beneficios vs. Mercado: Se prevé que los beneficios (17.1% al año) de DLB crezcan menos que el mercado US (17.4% al año).

Beneficios de alto crecimiento: Se prevé que los beneficios de DLB crezcan, pero no significativamente.

Ingresos vs. Mercado: Se prevé que los ingresos (5.4% al año) de DLB crezcan más despacio que el mercado de US (13.5% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 5.4% al año) de DLB crezcan más despacio que 20% al año.


Previsiones de crecimiento de los beneficios por acción


Rentabilidad financiera futura

ROE futura: Datos insuficientes para determinar si la rentabilidad financiera de DLB se prevé que sea elevada dentro de 3 años.


Descubre empresas en crecimiento

7D

1Y

7D

1Y

7D

1Y

Análisis de la empresa y estado de los datos financieros

DatosÚltima actualización (huso horario UTC)
Análisis de la empresa2026/09/10 00:13
Precio de las acciones al final del día2026/09/10 00:00
Beneficios2026/06/26
Ingresos anuales2025/09/26

Fuentes de datos

Los datos utilizados en nuestro análisis de empresas proceden de S&P Global Market Intelligence LLC. Los siguientes datos se utilizan en nuestro modelo de análisis para generar este informe. Los datos están normalizados, lo que puede introducir un retraso desde que la fuente está disponible.

PaqueteDatosMarco temporalEjemplo Fuente EE.UU. *
Finanzas de la empresa10 años
  • Cuenta de resultados
  • Estado de tesorería
  • Balance
  • Formulario SEC 10-K
  • Formulario SEC 10-Q
Estimaciones del consenso de analistas+3 años
  • Previsiones financieras
  • Objetivos de precios de los analistas
  • Informes de análisis
  • Blue Matrix
Precios de mercado30 años
  • Precios de las acciones
  • Dividendos, escisiones y acciones
  • Datos de mercado ICE
  • Formulario S-1 de la SEC
Propiedad10 años
  • Accionistas principales
  • Información privilegiada
  • Formulario SEC 4
  • Formulario SEC 13D
Gestión10 años
  • Equipo directivo
  • Consejo de Administración
  • Formulario SEC 10-K
  • Formulario SEC DEF 14A
Principales avances10 años
  • Anuncios de empresas
  • Formulario SEC 8-K

* Ejemplo para valores de EE.UU., para no EE.UU. se utilizan formularios y fuentes normativas equivalentes.

A menos que se especifique lo contrario, todos los datos financieros se basan en un periodo anual, pero se actualizan trimestralmente. Esto se conoce como datos de los últimos doce meses (TTM) o de los últimos doce meses (LTM). Más información.

Modelo de análisis y copo de nieve

Los detalles del modelo de análisis utilizado para generar este informe están disponibles en nuestra página de Github, también tenemos guías sobre cómo utilizar nuestros informes y tutoriales en Youtube.

Conozca al que diseñó y construyó el modelo de análisis Simply Wall St.

Métricas industriales y sectoriales

Simply Wall St calcula cada 6 horas nuestras métricas sectoriales y de sección. Los detalles de nuestro proceso están disponibles en Github.

Fuentes analistas

Dolby Laboratories, Inc. está cubierta por 13 analistas. 4 de esos analistas presentaron las estimaciones de ingresos o ganancias utilizadas como datos para nuestro informe. Las estimaciones de los analistas se actualizan a lo largo del día.

AnalistaInstitución
Vikram KesavabhotlaBaird
Patrick ShollBarrington Research Associates, Inc.
Eric WoldB. Riley Securities, Inc.

Toma mejores decisiones de inversión en cualquier lugar

Escanea para descargar
Abrir AppStoreAbrir Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
Ver fuentes de datos
Mercados
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Ideas de inversión
  • Empresas infravaloradas
  • Potentes generadores de dividendos
  • Compras con información privilegiada
  • Energía nuclear
  • Vehículos autónomos
  • Inteligencia artificial
  • Criptomonedas y blockchain
  • Ciberseguridad
  • Más ideas
Comunidades de acciones
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Herramientas y funciones
  • Seguimiento de la cartera
  • Buscador de valores y alertas
  • Narrativas y Valores de Feria
  • Calculadora de dividendos
Noticias y descubrimientos
  • Últimas noticias de stock
  • Incidencias del mercado global
  • El Foxhole
  • Ideas de inversión
  • Narrativas de la comunidad
  • Qué hay de nuevo
Simply Wall St
  • Planes y precios
  • Publicidad
  • Quiénes somos
  • Contacte con nosotros
  • Empleos
  • Centro de ayuda
  • Aprender a invertir en bolsa
  • Programa de afiliados
  • Empresas y negocios
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Términos y condiciones de uso
  • Política de privacidad
  • Términos de IA
  • Guía de servicios financieros